Who on the list is an antivaxxer?

On Fri, Mar 13, 2020 at 12:29 PM Meade Dillon via Mercedes <
mercedes@okiebenz.com> wrote:

> Thanks Gerry, some common sense there.
>
> " There’s a virus that the CDC currently estimated has killed between
> 20,000 and 45,000 people in the United States -- influenza. But only half
> the country gets that vaccine.
>
> There’s only 14 deaths [in the U.S., as of Friday afternoon] from COVID-19,
> but everybody would get a vaccine now.
>
> The point being: We’re not very good at assessing risk."
>
> I think we are up to 40 dead now from this Wuhan flu.
> -------------
> Max
> Charleston SC
>
>
> On Fri, Mar 13, 2020 at 12:24 PM archer75--- via Mercedes <
> mercedes@okiebenz.com> wrote:
>
> >
> >
> >
> > Philly vaccine pioneer: We can’t rush a coronavirus vaccine | Q&A
> >
> >
> > At a White House news conference Tuesday, Anthony Fauci, the head of the
> > National Institute of Allergy and Infectious Disease, told President
> Donald
> > Trump a coronavirus vaccine would likely not be available within the next
> > year or two. Trump responded: “I like the sound of a couple of months
> > better.”
> >
> > But a vaccine is not going to be available in the next couple of months,
> > and according to Dr. Paul Offit, that’s appropriate. Offit, director of
> the
> > Vaccine Education Center at Children’s Hospital of Philadelphia, is the
> > co-developer of the rotavirus vaccine. It took roughly 26 years to
> perfect
> > that protection against a disease that, according to the Centers for
> > Disease Control and Prevention, was the leading cause for severe diarrhea
> > in children before the vaccine’s introduction in 2006.
> >
> > Why is it unrealistic to expect a vaccine for coronavirus in a few
> months?
> >
> > Nobody’s ever seen this virus before. Therefore, if you’re interested in
> > making a vaccine, you first had access to that virus only a couple months
> > ago. That’s not long.
> >
> > [To make a vaccine] you first need to make a decision as to what approach
> > you want to take. Then you have to do extensive animal model testing to
> > make sure that the approach that you’ve taken is safe in animals, and
> that
> > it induces an immune response which would likely be protective. Then you
> > gradually do studies in people to make sure it’s safe, and then to make
> > sure that it induces an immune response. That takes time, a lot of time,
> > typically years. Then and only then, are you ready to put it into people
> to
> > see whether or not it works in an outbreak situation.
> >
> > In 2018, after the World Health Organization declared an Ebola outbreak
> in
> > the Democratic Republic of Congo, there was an experimental vaccine very
> > quickly.
> >
> > I think people got fooled by Ebola. When the outbreak occurred in West
> > Africa and we had a vaccine pretty much that rolled off shelf within
> weeks,
> > people thought, Ha! That’s easy.
> >
> > But what they didn’t realize is people have been working on an Ebola
> > vaccine for 20 years. They’ve done the animal model testing. They’ve done
> > the testing to make sure that the vaccine was safe and was immunogenic.
> >
> > But that’s not true here. This is a new virus. So we’re starting from
> > scratch.
> >
> > What is it about this virus that makes people confident that a vaccine
> > will be available?
> >
> > I don’t know. You know, I’d say about 15% to 20% of the respiratory
> > infections that we see in our hospital in the winter months are [types
> of]
> > coronavirus. This is a virus that has been around for 50 years.
> >
> > But here are these three newer strains of coronavirus — MERS, SARS, and
> > now this COVID-19. The first two viruses, SARS and MERS, have come and
> gone.
> >
> > I think this [COVID-19] virus likely will come back because it’s
> > different. If you were infected with SARS or MERS viruses, you were sick.
> > And it’s very easy to tell who was sick and who wasn’t. You could then
> > quarantine those people — put a moat around them, if you will — so that
> > they wouldn’t infect others. So those infections quickly died out. This
> > virus is more like flu. It spreads in a similar manner to flu by
> > respiratory droplet. It’s about as contagious as flu. It has the same set
> > of symptoms as flu. And I think in the end, frankly, it’s going to have
> the
> > same mortality rate as flu.
> >
> > There are certainly human studies showing that if you’re infected with a
> > coronavirus — meaning one of the typical coronaviruses — you can have
> > immunity to that strain for at least a year and probably longer. That’s
> > encouraging. If natural infection can protect you, then it’s encouraging
> > that it can produce an immune response which is protective and which you
> > should be able to mimic with vaccination.
> >
> > Vaccine development is tightly regulated. How much of that is about
> safety
> > vs. red tape?
> >
> > If you’re going to be testing this in otherwise healthy people who are
> > very, very unlikely to die from this infection, you better make sure it’s
> > safe. So you want those regulations in place.
> >
> > An example is the dengue vaccine. When it was tested in Latin America and
> > Philippines, it was found to actually increase your risk of dengue shock
> > syndrome. Children who were less than 9 years of age, who had never been
> > exposed to the virus before, were actually more likely to be hurt by the
> > vaccine than helped by it. Now, you only knew that from doing large
> > clinical trials with tens of thousands of people.
> >
> > The history of medical breakthroughs is littered with tragedy. You want
> to
> > make sure that things are safe.
> >
> > What do you think is behind the apparent willingness to skirt the rules
> to
> > rush a vaccine?
> >
> > I think that because we falsely overrate, or incorrectly rate, what the
> > mortality rate is, we’re willing to accept that things will be rushed
> > through. In fact, coronavirus doesn’t have a high mortality rate.
> >
> > There’s a virus that the CDC currently estimated has killed between
> 20,000
> > and 45,000 people in the United States -- influenza. But only half the
> > country gets that vaccine.
> >
> > There’s only 14 deaths [in the U.S., as of Friday afternoon] from
> > COVID-19, but everybody would get a vaccine now.
> >
> > The point being: We’re not very good at assessing risk.
> >
> >
> >
> https://www.inquirer.com/health/coronavirus/coronavirus-covid-19-vaccine-trump-paul-offit-20200306.html
> >
> > Gerry
> > ........................................................................
> >
> >
> > _______________________________________
> > http://www.okiebenz.com
> >
> > To search list archives http://www.okiebenz.com/archive/
> >
> > To Unsubscribe or change delivery options go to:
> > http://mail.okiebenz.com/mailman/listinfo/mercedes_okiebenz.com
> >
> >
> _______________________________________
> http://www.okiebenz.com
>
> To search list archives http://www.okiebenz.com/archive/
>
> To Unsubscribe or change delivery options go to:
> http://mail.okiebenz.com/mailman/listinfo/mercedes_okiebenz.com
>
>
_______________________________________
http://www.okiebenz.com

To search list archives http://www.okiebenz.com/archive/

To Unsubscribe or change delivery options go to:
http://mail.okiebenz.com/mailman/listinfo/mercedes_okiebenz.com

Reply via email to